GREAT CHEMISTRY CURES

LIVE

Serial Number

97277880

Owner

Enanta Pharmaceuticals, Inc.

Attorney

Joshua S. Jarvis, Esq.

First Use Date

Aug 9, 2024

Filing Date

Feb 22, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

GREAT CHEMISTRY CURES Trademark

Serial Number: 97277880 • Registration: 7747025

GREAT CHEMISTRY CURES is a trademark filed by Enanta Pharmaceuticals, Inc. on February 22, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Enanta Pharmaceuticals, Inc. (6 trademarks)

750 Main Street
Cambridge, MA 02139

Entity Type: 03

Legal Representation

Attorney of Record

Joshua S. Jarvis, Esq.

654 trademarks filed View all →

Correspondence Address

Joshua S. Jarvis, Esq. FOLEY HOAG LLP

155 SEAPORT BOULEVARD

BOSTON, MA 02210

United States

Trademark Details

Filing Date

February 22, 2022

Registration Date

April 1, 2025

First Use Anywhere

August 9, 2024

First Use in Commerce

August 9, 2024

Published for Opposition

December 27, 2022

Goods & Services

Pharmaceutical preparations for the treatment of viral infections and hepatic diseases and disorders

Research and development services in the field of identification of compounds as potential therapeutic products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 1, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Apr 1, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 10, 2025 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 10, 2025 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Mar 5, 2025 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 2, 2025 AITU

USE AMENDMENT FILED

Dec 19, 2024 IUAF

TEAS STATEMENT OF USE RECEIVED

Dec 19, 2024 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 6, 2024 EXRA

SOU EXTENSION 3 GRANTED

Aug 6, 2024 EX3G

SOU EXTENSION 3 FILED

Aug 6, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Aug 6, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 14, 2024 EXRA

SOU EXTENSION 2 GRANTED

Feb 13, 2024 EX2G

SOU EXTENSION 2 FILED

Feb 13, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Feb 13, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 18, 2023 EXRA

SOU EXTENSION 1 GRANTED

Aug 16, 2023 EX1G

SOU EXTENSION 1 FILED

Aug 16, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Aug 16, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 21, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 27, 2022 NPUB

PUBLISHED FOR OPPOSITION

Dec 27, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 7, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 18, 2022 CNSA

ASSIGNED TO EXAMINER

Nov 14, 2022 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 28, 2022 NWOS

NEW APPLICATION ENTERED

Feb 25, 2022 NWAP

Related Trademarks

More from this Owner

Serial #97248094

ENANTA PHARMACEUTICALS

Serial #97248094

More in Same Class

BIVICTRIX

BRAINY KIDS

FUEL FOR A MINDFUL WORLD

BI-CYGNI

TWINSTRAND BIOSCIENCES

TYCNEEK